Table 2.
Estimated chronic pain prevalence in those with ADHD
| Total | Females | Males | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Probability (%) | 95% CI (%) | p value | Probability (%) | 95% CI (%) | p value | Probability (%) | 95% CI (%) | p value | |
| Chronic pain | |||||||||
| Baseline T1 2009–2011 | 74.3% | 65.4–81.6 | 90.4% | 78.9–96.0 | 59.2% | 48.0–69.2 | |||
| Follow-up T2 2012–2014 | 62.3% | 51.9–71.7 | 0.027 | 87.9% | 74.7–94.7 | 0.57 | 41.9% | 30.7–53.9 | 0.021 |
| Follow-up T3 2018–2019 | 66.4% | 56.0–75.4 | 0.14 | 85.4% | 71.4–93.2 | 0.29 | 50.5% | 38.1–62.9 | 0.26 |
| Multisite pain | |||||||||
| Baseline T1 2009–2011 | 22.9% | 15.9–31.8 | 48.9% | 36.2–61.7 | 8.9% | 4.0–18.6 | |||
| Follow-up T2 2012–2014 | 25.4% | 17.4–35.6 | 0.60 | 55.3% | 41.3–68.5 | 0.46 | 8.8% | 3.7–19.4 | 0.96 |
| Follow-up T3 2018–2019 | 21.5% | 14.2–31.3 | 0.76 | 39.4% | 26.8–53.4 | 0.27 | 11.6% | 5.2–23.7 | 0.48 |
The level of significance was set to p < 0.05 (in bold)
Based on mixed-effect logistic regression with pain as dependent variable and time as categorical covariate. p values for change from baseline